|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
After hours 17:02:04 | |||
| 170.68 USD | +3.06% |
|
172.00 | +0.77% |
| 12:53pm | Gilead's HIV Franchise Supports Growth Outlook, RBC Says | MT |
| 10:06am | UBS Adjusts Gilead Sciences Price Target to $195 From $175, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +3.06% | +8.58% | +39.06% | +44.03% | +163.07% | 205B |  | | |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
